Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611544 · ClinicalTrials.gov registry record · NA
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02611544: Completed NA study, sponsored by Indiana University.
NCT02611544 is a NA study that has completed, run by Indiana University. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02611544, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the recognized prevalence, persistence, and suffering associated with FCR, effective and accessible treatments for FCR are lacking and urgently needed. Our long-term goal is to develop, evaluate, and implement effective behavioral interventions for cancer survivors suffering with FCR.
Primary Outcome
As measured by Fear of Cancer Recurrence Inventory (FCRI)
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Survivorship Education
- BEHAVIORAL Acceptance and Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-12-01 |
| Phase | NA |
What the finished NCT02611544 record still lists
NCT02611544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT02611544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02611544 about?
NCT02611544 is a clinical study titled "Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors". Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the ...
What is the current status of trial NCT02611544?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-12. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02611544?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Survivorship Education (BEHAVIORAL), Acceptance and Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02611544?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02611544's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia